H. pylori, Zonulin & Leaky Gut: What the Research Really Shows

By CJ Faucher, FNP-BC

If you’ve been dealing with bloating, reflux, fatigue, food sensitivities, brain fog, or digestive symptoms that haven’t resolved with diet changes or supplements, it’s worth understanding a research area that’s still developing: the relationship between H. pylori, a protein called zonulin, and intestinal permeability  sometimes called “leaky gut.”

In my years as a Family Nurse Practitioner, I’ve learned to treat patient symptoms as clues, not isolated problems. This connection between H. pylori, zonulin, and gut barrier health is genuinely interesting, and it’s one I bring up often with patients. It’s also more uncertain than a lot of online content suggests, so I want to walk through what’s well-established and what’s still hypothesis, so you can have an informed conversation with your own provider.

What Is H. pylori?

H. pylori is a spiral-shaped bacterium that colonizes the stomach lining. It’s one of the most common chronic bacterial infections worldwide, with estimates suggesting it colonizes roughly half the global population, though prevalence varies significantly by region and has been declining in many high-income countries.

Most people with H. pylori never develop symptoms. When it does cause problems, well-established effects include:

• Gastritis
• Peptic ulcers
• Acid reflux and heartburn
• Bloating, burping, nausea
• Increased risk of gastric cancer with long-term untreated infection

H. pylori has also been studied for associations with extra-digestive issues. Iron deficiency anemia, vitamin B12 deficiency, and certain skin conditions have the most supporting evidence. Associations with brain fog, fatigue, histamine intolerance, and broader autoimmune activity are reported in some studies but are far less consistently established, and a causal relationship hasn’t been confirmed.

What Is Zonulin?

Zonulin is a protein, first described by Dr. Alessio Fasano’s research group, that’s involved in regulating tight junctions the connections between cells lining the intestinal wall. In laboratory and animal models, increased zonulin has been linked to looser tight junctions and increased intestinal permeability.

Here’s an important caveat I share with my patients: there’s legitimate scientific debate about zonulin testing in practice. Commercial zonulin assays, including those used in stool tests, have been criticized in the literature for inconsistent results and potential cross-reactivity with other proteins (such as complement C3) that aren’t actually zonulin. This doesn’t mean the underlying biology is wrong, but it does mean a zonulin number on a lab report should be interpreted cautiously rather than treated as a precise, validated measurement on its own.

What Exactly Is Leaky Gut?

“Leaky gut” isn’t a formal medical diagnosis. You won’t find it in standard diagnostic manuals. It’s a descriptive term for increased intestinal permeability, a real and measurable phenomenon that’s an active area of research.

Increased permeability is well-documented as a feature of several conditions, including celiac disease, inflammatory bowel disease, and some autoimmune diseases. What’s far less settled is the direction of causation: does increased permeability drive disease, or is it a downstream consequence of inflammation that’s already happening for other reasons? Most researchers in this space, including Fasano, describe it as likely bidirectional and context-dependent, not a single root cause waiting to be found and fixed.

How H. pylori May Influence Gut Barrier Function

Several mechanisms have been proposed and studied, mostly in lab and animal models:

1. Increased Inflammation

H. pylori reliably triggers local gastric inflammation. Inflammatory signaling has been shown in some studies to affect tight junction proteins, though the degree to which this translates into clinically meaningful permeability changes in humans is still being studied.

2. Immune Activation

Chronic H. pylori colonization keeps the local immune system engaged. Sustained immune activity is one proposed pathway toward barrier changes, though the human evidence here is more limited than the inflammation pathway.

3. Microbiome Shifts

H. pylori doesn’t exist in isolation. It can influence the broader gastric and gut microbial community. Dysbiosis has its own associations with barrier function, somewhat independent of H. pylori specifically.

4. Oxidative Stress

H. pylori infection is associated with increased oxidative stress in gastric tissue, which has plausible but not definitively proven effects on barrier integrity in humans.

I want to be direct about where the evidence actually stands: most of the H. pylori-to-zonulin-to-leaky-gut chain you’ll read about online is built from mechanisms shown in cell or animal studies, plus correlational human data. Few studies have directly tested whether treating H. pylori measurably lowers zonulin or improves clinical outcomes tied to permeability. That’s a meaningful gap between “plausible mechanism” and “established clinical pathway,” and it’s one I think patients deserve to know about.

Why Comprehensive Testing Can Still Be Useful

A reasonable clinical point holds regardless of where the zonulin research lands: gut symptoms are often multifactorial. A patient can have H. pylori, dysbiosis, low digestive enzyme function, and inflammation all at once, and a test that only checks for one of these can miss the others entirely.

This is the actual, defensible case for comprehensive stool testing like the GI-MAP with Zonulin, not that it definitively diagnoses leaky gut, but that it surveys multiple plausible contributors to symptoms from a single sample. That’s genuinely useful when narrower, single-marker testing hasn’t explained what a patient is experiencing.

The test evaluates:

• H. pylori, including select virulence markers
• Zonulin (interpreted with the caveats above)
• Microbiome balance commensal and opportunistic organisms
• Parasites
• Yeast and fungal markers
• Digestive function markers
• Inflammatory markers
• Secretory IgA, a marker of mucosal immune activity

Learn more about the GI-MAP with Zonulin

H. pylori and Food Sensitivities

One of the most common things I hear from patients is, “I can’t tolerate foods I used to eat without a problem.”

There can be several reasons for this, but increased intestinal permeability is one potential contributor under active study. When larger food particles cross a compromised intestinal barrier, the immune system may begin recognizing those foods as threats, which can contribute to food sensitivities, histamine-type reactions, and digestive discomfort.

While food sensitivities deserve attention on their own, it’s worth asking why they developed in the first place. Sometimes part of the answer lies within the gut barrier. Sometimes it doesn’t. That’s exactly why broader testing, rather than guessing, can be valuable.

H. pylori and Autoimmune Conditions

Researchers continue exploring the relationship between intestinal permeability and autoimmune disease. Autoimmunity is complex and multifactorial, and increased intestinal permeability is frequently discussed as one contributing factor among many, not a single explanatory cause.

A compromised gut barrier may expose the immune system to substances that promote ongoing immune activation. For patients with autoimmune concerns, evaluating both H. pylori status and zonulin alongside their broader clinical picture may provide useful, if incomplete, information.

Who Might Consider GI-MAP with Zonulin Testing?

Broader stool testing may be worth discussing with your provider if you have persistent, unexplained:

• Chronic bloating, reflux, or heartburn
• Constipation or diarrhea
• Food sensitivities or histamine-type reactions
• Fatigue or brain fog
• Skin conditions
• Nutrient deficiencies
• Autoimmune symptoms
• Symptoms that haven’t responded to dietary changes, supplements, or prior treatment

It’s most useful as one input alongside your full clinical picture, your symptoms, history, and other testing, not as a standalone diagnostic tool.

Explore the GI-MAP with Zonulin test

Can Gut Barrier Function Be Improved?

The encouraging news is that the intestinal lining has real regenerative capacity. The first step is identifying factors that may be contributing to barrier dysfunction, which can include:

• H. pylori or other chronic infections
• Dysbiosis
• Chronic stress
• Heavily processed foods
• Alcohol
• Certain medications
• Environmental exposures

H. pylori itself has clear, guideline-based treatment protocols, typically a combination of antibiotic and acid-suppression therapy, and treating a confirmed infection is well-supported regardless of what’s happening with zonulin specifically.

For barrier support more broadly, the evidence-informed approach focuses on addressing known contributors: treating any active infection, supporting a diverse microbiome, moderating alcohol and ultra-processed food intake, and managing chronic stress, rather than relying on any single supplement or protocol marketed specifically as a “leaky gut cure.” I’d encourage skepticism toward any product claiming to definitively repair intestinal permeability. The research isn’t at a point where such promises are well-supported.

The Power of Looking at the Whole Picture

One of the more common mistakes I see in healthcare is focusing on isolated symptoms instead of asking what’s driving them. Symptoms matter, but they rarely tell the entire story on their own.

When we evaluate H. pylori, zonulin, microbiome balance, inflammation, digestive function, and immune activity together, we get a far more complete picture of gut health than any single marker provides. That’s the actual value of comprehensive testing: not a guaranteed answer, but better data to work from.

Final Thoughts

H. pylori is more than a stomach infection. For some people, it may influence inflammation, microbiome balance, immune function, and intestinal permeability, though the strength of that connection varies by symptom and is still being actively researched. Zonulin offers a window into gut barrier health, with real caveats about how it’s measured. Together, these markers can offer useful clues about persistent symptoms, without being the whole answer on their own.

If you’ve been dealing with digestive symptoms, food sensitivities, inflammation, fatigue, or other unexplained health concerns that haven’t improved with standard approaches, broader testing can be a reasonable next step, ideally as part of a conversation with a physician or nurse practitioner who can interpret results in the context of your full history.

Order the GI-MAP with Zonulin test

Need help understanding your results? Schedule a 45-minute consultation with one of our specialists by CLICKING HERE or send us an email. We’re happy to provide additional support as you navigate your results and next steps.

---

References

1. Fasano A. Zonulin and Its Regulation of Intestinal Barrier Function: The Biological Door to Inflammation, Autoimmunity, and Cancer. Physiol Rev. 2011;91(1):151-175.
2. Fasano A. Leaky Gut and Autoimmune Diseases. Clin Rev Allergy Immunol. 2012;42(1):71-78.
3. Camilleri M. Leaky Gut: Mechanisms, Measurement and Clinical Implications in Humans. Gut. 2019;68(8):1516-1526.
4. Malfertheiner P, Megraud F, O’Morain CA, et al. Management of Helicobacter pylori Infection: Maastricht VI/Florence Consensus Report. Gut. 2022;71(9):1724-1762.
5. Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. American Journal of Gastroenterology. 2017;112(2):212-239.
6. Vancamelbeke M, Vermeire S. The Intestinal Barrier: A Fundamental Role in Health and Disease. Expert Review of Gastroenterology & Hepatology. 2017;11(9):821-834.
7. Pellicano R, Ribaldone DG, Fagoonee S, Astegiano M. Helicobacter pylori and Extragastric Diseases. Helicobacter. 2020;25(Suppl 1):e12741.
8. Odenwald MA, Turner JR. The Intestinal Epithelial Barrier: A Therapeutic Target? Nature Reviews Gastroenterology & Hepatology. 2017;14(1):9-21.
9. Schoultz I, Keita ÅV. The Intestinal Barrier and Current Techniques for the Assessment of Gut Permeability. Cells. 2020;9(8):1909.
10. Singh P, Silvester J, Chen X, et al. Serum Zonulin is Elevated in Individuals with Increased Intestinal Permeability. Digestive Diseases and Sciences. 2021;66:3479-3488.

Disclaimer

This article is for educational and informational purposes only and should not be construed as medical advice, diagnosis, or treatment. The content reflects an integrative and functional medicine perspective and is not intended to replace the advice of your physician, nurse practitioner, or other qualified healthcare provider. Never disregard professional medical advice or delay seeking care because of something you have read on this website.

Laboratory testing, including the GI-MAP with Zonulin, is intended to provide information that may help guide health and wellness decisions but should always be interpreted within the context of your complete medical history, symptoms, and clinical presentation. Individual results may vary, and no laboratory test can diagnose, treat, cure, or prevent any disease on its own.

If you are experiencing severe abdominal pain, gastrointestinal bleeding, unexplained weight loss, difficulty swallowing, persistent vomiting, or other concerning symptoms, seek prompt medical evaluation.